Omeros (OMER) Plans to File Patent Infringment Suit vs. Par Pharma
Tweet Send to a Friend
Omeros (NASDAQ: OMER) in response to investor questions, announced that it plans to file a patent infringement lawsuit against Par ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE